Dose-Modified Ifosfamide, Epirubicin, and Etoposide is a Safe and Effective Salvage Therapy with High Peripheral Blood Stem Cell Mobilization Capacity for Poorly Mobilized Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphoma Patients

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy alone or in combination with rituximab in treating high-risk non-Hodgkin’s lymphoma

Chinese Journal of Cancer ◽

10.1186/s40880-015-0045-3 ◽

2015 ◽

Vol 34 (3) ◽

Cited By ~ 5

Author(s):

Yuankai Shi ◽

Ping Zhou ◽

Xiaohong Han ◽

Xiaohui He ◽

Shengyu Zhou ◽

...

Keyword(s):

Stem Cell ◽

High Risk ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704413 ◽

2004 ◽

Vol 33 (7) ◽

pp. 703-707 ◽

Cited By ~ 18

Author(s):

T Endo ◽

N Sato ◽

Y Mogi ◽

K Koizumi ◽

M Nishio ◽

...

Keyword(s):

Stem Cell ◽

B Cell ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patients

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1704106 ◽

2003 ◽

Vol 32 (2) ◽

pp. 139-143 ◽

Cited By ~ 27

Author(s):

M Benekli ◽

T Hahn ◽

F Shafi ◽

A Qureshi ◽

A R Alam ◽

...

Keyword(s):

Stem Cell ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphoma

Leukemia & Lymphoma ◽

10.1080/10428190500468584 ◽

2006 ◽

Vol 47 (7) ◽

pp. 1290-1294 ◽

Cited By ~ 10

Author(s):

Chitra Hosing ◽

Rima M. Saliba ◽

Martin Körbling ◽

Sandra Acholonu ◽

John Mcmannis ◽

...

Keyword(s):

Stem Cell ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

High Dose ◽

Intermediate Grade ◽

Non Hodgkin's Lymphoma ◽

Peripheral Blood Stem Cell Mobilization with Cyclophosphamide in Combination with G-CSF, GM-CSF, or Sequential GM-CSF/G-CSF in Non-Hodgkin's Lymphoma Patients: A Randomized Prospective Study

Journal of Hematotherapy & Stem Cell Research ◽

10.1089/15258160050196786 ◽

2000 ◽

Vol 9 (5) ◽

pp. 737-748 ◽

Cited By ~ 28

Author(s):

Yair Gazitt ◽

Natalie Callander ◽

Cesar O. Freytes ◽

Paul Shaughnessy ◽

Qun Liu ◽

...

Keyword(s):

Stem Cell ◽

Prospective Study ◽

Peripheral Blood ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

Gm Csf ◽

Non Hodgkin's Lymphoma ◽

Efficacy of just-in-time plerixafor rescue for Hodgkin's lymphoma patients with poor peripheral blood stem cell mobilization

Transfusion ◽

10.1111/trf.12594 ◽

2014 ◽

Vol 54 (8) ◽

pp. 2015-2021 ◽

Cited By ~ 7

Author(s):

Shan Yuan ◽

Auayporn Nademanee ◽

Mark Kaniewski ◽

Joycelynne Palmer ◽

Sepideh Shayani ◽

...

Keyword(s):

Stem Cell ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Blood Stem Cell ◽

Stem Cell Mobilization ◽

Hodgkin's Lymphoma ◽

Just In Time ◽

Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma

British Journal of Haematology ◽

10.1046/j.1365-2141.1998.00572.x ◽

1998 ◽

Vol 100 (2) ◽

pp. 348-350 ◽

Cited By ~ 34

Author(s):

Toshihiro Miyamoto ◽

Hisashi Gondo ◽

Yasushi Miyoshi ◽

Hirokazu Shigematsu ◽

Toshio Minematsu ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Blood Stem Cell ◽

Hodgkin's Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Blood Stem Cell Transplantation

Immunotherapy with rituximab/interleukin 2 (IL-2) following autologous peripheral blood stem cell transplant (ASCT) as treatment for CD20 positive non-hodgkin’s lymphoma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2005.11.356 ◽

2006 ◽

Vol 12 (2) ◽

pp. 116

Author(s):

L.A. Holmberg ◽

D. Maloney ◽

T. Gooley ◽

W.I. Bensinger

Keyword(s):

Stem Cell ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Stem Cell Transplant ◽

Interleukin 2 ◽

Blood Stem Cell ◽

Hodgkin's Lymphoma ◽

Cell Transplant ◽

Non Hodgkin's Lymphoma

Rituximab and Interleukin 2 (IL2) as treatment for CD20+ non-Hodgkin's lymphoma (NHL) following autologous peripheral blood stem cell transplant (ASCT)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.6534 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 6534-6534 ◽

Cited By ~ 1

Author(s):

L. A. Holmberg ◽

D. G. Maloney ◽

W. I. Bensinger

Keyword(s):

Stem Cell ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Stem Cell Transplant ◽

Interleukin 2 ◽

Blood Stem Cell ◽

Hodgkin's Lymphoma ◽

Cell Transplant ◽

Non Hodgkin's Lymphoma

A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.02244.x ◽

2000 ◽

Vol 110 (3) ◽

pp. 631-637 ◽

Cited By ~ 32

Author(s):

C. Jacquy ◽

A. Sorée ◽

F. Lambert ◽

A. Bosly ◽

A. Ferrant ◽

...

Keyword(s):

Stem Cell ◽

Quantitative Study ◽

Peripheral Blood ◽

Hodgkin’S Lymphoma ◽

Large Cell ◽

Blood Stem Cell ◽

Hodgkin's Lymphoma ◽

Malignant Cells ◽

Non Hodgkin's Lymphoma